Aarey Drugs & Pharmaceuticals Limited — Results, 17-02-2025: Integrated Filing- Financial

The Board of Directors of Aarey Drugs & Pharmaceuticals has approved the unaudited financial results for the quarter and half-year ended December 31, 2024. This meeting was held yesterday evening. The financial results, along with the Limited Review Report and certifications from the MD/CFO, indicate the company's ongoing operations in the bulk drugs sector.

This update suggests a stable operational performance, with no significant deviations noted in financial activities. For investors, this could indicate a positive outlook, as the company's governance appears sound and management is actively addressing financial reporting matters.